CTOs on the Move

Grace Management

www.gracemanagement.com

 
Grace Management, Inc. is a nationally recognized leader in delivering senior living management service. Grace Management was established in 1984 and has built a reputation not only as a business leader in the senior living industry, but also as having developed a family-driven approach. Grace Management communities include independent living, cottage and estate homes, assisted living, and memory care that offer a diverse array of services and amenities catered to the individual.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

InterHealth Nutraceuticals

InterHealth Nutraceuticals, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. InterHealth Nutraceuticals, Inc is based in Benicia, CA. You can find more information on InterHealth Nutraceuticals, Inc at www.interhealthusa.com

Keystone Peer Review Organization

Keystone Peer Review Organization is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Workit Health

Workit Health offers online, on-demand evidence-based addiction treatment. Through our mobile and web apps, members meet with clinicians, counselors, and coaches and work towards self-set recovery goals. Our interactive curriculum of over 800 engaging online courses about addiction keep members on track in the comfort of home. We offer 24/7 recovery that fits into daily life, designed by experts.

1life Healthcare Inc

1life Healthcare Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.